Please check out this new story about Cas12a-based multiplex gene editing in cancer drug target discovery from Shi lab! Congrats to my great colleagues!!!
We are excited to share the publication of our manuscript, “High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening,” in @NatureComms today!View quoted post on X
nature.com/articles/s4146…
